Clinical Trial Update: CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CS0159 in Chinese patients with primary sclerosing cholangitis is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• CS0159

Snippet

Sponsor: Cascade Pharmaceuticals, Inc | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING